McGlone Suttner Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
McGlone Suttner Wealth Management's GILD Position: Q2 2026 in Review
McGlone Suttner Wealth Management increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $22.9K and bringing the position to 4,593 shares worth $580K. The position accounts for 0.07% of the portfolio, ranked #119.
McGlone Suttner Wealth Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $711K in Q4 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- McGlone Suttner Wealth Management held 4,593 shares of Gilead Sciences worth $580K as of Q2 2026.
- McGlone Suttner Wealth Management bought 174 Gilead Sciences shares in Q2 2026, an estimated $22.9K.
- Gilead Sciences made up 0.07% of McGlone Suttner Wealth Management's portfolio in Q2 2026, its #119 holding.
- McGlone Suttner Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
- McGlone Suttner Wealth Management's Gilead Sciences position peaked at $711K in Q4 2025.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on McGlone Suttner Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.